心臟去顫器全球市場規模、佔有率、成長分析、按產品、最終用戶 - 產業預測，2024-2031 年

Global Defibrillator Market Size, Share, Growth Analysis, By Product(Implantable Cardioverter Defibrillators (ICD), and External Defibrillators (ED)), By End-User(Hospital, Pre-Hospital) - Industry Forecast 2024-2031

出版日期: 2024年03月29日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球心臟去顫器市場規模為127.6億美元，從2023年的136.8億美元成長到2031年的238.6億美元，預測期間（2024-2031年）複合年成長率為7.20%。

市場的成長受到幾個關鍵因素的推動，包括產品技術的進步、心臟麻痹案例的增加、社會意識的提高以及政府和醫療機構的支持措施。這項進展的一個例子是澳洲 Rapid Response Revival Research Ltd. 的突破性 CellAED 於 2021 年獲得了 CE 認證，CellAED 是世界上首款專為家庭使用而設計的個人AED。儘管預防和治療方面取得了進展，但心臟麻痹仍然是心血管死亡的一個重要原因，這促使植入式心臟整流去顫器(ICD) 和體外心臟去顫器，需求不斷增加。例如，Ami Italia 提供 Saver One、Geo Saver 和 Smarty Saver 系列等心臟去顫器，多功能 Smarty 系列可用於各種情況，包括急救車輛、醫療設施和公共場所。，適用於醫務人員和非醫務人員。同時，微創在中國心律管理市場佔據主導地位，憑藉多元化的產品系列和強大的產品線，2022年上半年收益大幅成長95%。此外，諸如杜拜救護車服務管理局 (DCAS) 向全市各地分發 80 台 AED 等舉措，以及通過 DCAS 的 Help Me 應用程式建立熟練急救人員網路等舉措也正在進行中。像“This Town Saves Now”這樣的節目。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

Medtronic plc
Philips Healthcare
Abbott Laboratories
Boston Scientific Corporation
ZOLL Medical Corporation
Physio-Control, Inc.（a Stryker Company）
Cardiac Science Corporation
Nihon Kohden Corporation
Koninklijke Philips NV.
SCHILLER AG
CU Medical Systems, Inc.
Progetti Srl
Mindray Medical International Limited
Defibtech, LLC
LivaNova PLC
Cardionet, LLC（a BioTelemetry Company）
Biotronik SE & Co. KG
Welch Allyn（a Hill Rom Company）
Cardiac Science Corporation
Physio-Control, Inc.（a Stryker Company）

簡介目錄

Product Code: SQMIG35A2240

Global Defibrillator Market size was valued at USD 12.76 Billion in 2022 and is poised to grow from USD 13.68 Billion in 2023 to USD 23.86 Billion by 2031, at a CAGR of 7.20% during the forecast period (2024-2031).

The growth of the market is being propelled by several key factors, including advancements in product technology, an uptick in sudden cardiac arrest cases, heightened public awareness, and supportive initiatives from governmental and healthcare bodies. An example of this progress is evident in Rapid Response Revival Research Ltd., an Australian company, obtaining CE certification in 2021 for their groundbreaking CellAED, the world's first personal AED designed for home use, which facilitated the company's expansion plans. Despite strides in prevention and treatment, sudden cardiac arrest remains a significant contributor to cardiovascular mortality, fostering innovation and driving demand for implantable cardioverter defibrillators (ICDs) and external defibrillators. Ami Italia, for instance, offers a range of defibrillators like the Saver One, Geo Saver, and Smarty Saver lines, with the versatile Smarty Series finding application in various settings such as emergency vehicles, medical facilities, and public spaces, catering to both medical and non-medical personnel. Meanwhile, Microport dominates China's cardiac rhythm management market, recording a substantial revenue surge of 95% in the first half of 2022, owing to its diverse product portfolio and robust pipeline. Additionally, increasing awareness of cardiovascular diseases in emerging markets is driving market growth, alongside initiatives like the Dubai Corporation for Ambulance Services (DCAS) distributing 80 AEDs to diverse locations across the city, complemented by volunteer training through programs like This Town Saves Now, aimed at establishing a network of skilled responders via DCAS' Help Me app.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Defibrillator Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Defibrillator Market Segmental Analysis

The global defibrillator market is segmented based on product, end user, and region. Based on product, the market is segmented into implantable cardioverter defibrillators (ICD), and external defibrillators (ED). With respect to categorization by end-use, the market is segmented into hospital, pre-hospital, public access market, alternate care market, and home healthcare. Regionwise, the global defibrillator market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Defibrillator Market

The surge in specific target diseases is exerting a profound influence on global healthcare. Cardiovascular ailments, encompassing coronary artery disease and cardiac arrest, impact a considerable segment of the world's populace, resulting in a rising mortality rate. In 2021, data from the Centers for Disease Control and Prevention (CDC) linked approximately 695,000 deaths in the United States to cardiovascular diseases. Particularly, coronary artery disease heightens the risk of sudden cardiac death due to arrhythmias. A 2022 report from the Coronary Artery Disease Foundation indicates an annual occurrence of roughly 356,000 out-of-hospital cardiac arrests (OHCA) in the United States. Lifestyle-related factors such as obesity, hypertension, dyslipidemia, and diabetes significantly contribute to the heightened risk of various cardiovascular conditions. Moreover, the global aging populace serves as a pivotal factor driving the escalating prevalence of cardiovascular diseases. Aging correlates with an increased susceptibility to developing ventricular arrhythmias, primarily attributable to the progressive degradation and heightened complexity in the structure and functionality of the heart, thereby fostering a burgeoning prevalence of arrhythmias among the elderly.

Restraints in the Global Defibrillator Market

The adoption of defibrillators, particularly advanced ones such as ICDs and implantable devices, may be hindered by their relatively high costs, which can constrain market expansion, especially in areas with constrained healthcare budgets or insufficient insurance coverage.

Market Trends of the Global Defibrillator Market

The defibrillator market is experiencing swift technological progressions focused on improving device functionality, user-friendliness, and patient results. Prominent advancements involve the incorporation of artificial intelligence (AI) algorithms to enhance the precision of cardiac rhythm detection, wireless connectivity for distant monitoring and data transfer, and upgraded user interfaces for simplified operation.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Defibrillator Market by Product

Market Overview
Implantable Cardioverter Defibrillators (ICD)
and External Defibrillators (ED)

Global Defibrillator Market by End-User

Market Overview
Hospital
Pre-Hospital
Public Access Market
Alternate Care Market
and Home Healthcare

Global Defibrillator Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZOLL Medical Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Physio-Control, Inc. (a Stryker Company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardiac Science Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nihon Kohden Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips NV.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SCHILLER AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CU Medical Systems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Progetti S.r.l.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mindray Medical International Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Defibtech, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardionet, LLC (a BioTelemetry Company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Welch Allyn (a Hill Rom Company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardiac Science Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Physio-Control, Inc. (a Stryker Company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments